Transaction DateRecipientSharesTypePriceValue
26th October 2020Andreas G Frank5,500Open or private sale$91.45$502,975.00
19th October 2020Andreas G Frank5,500Open or private sale$89.90$494,450.00
12th October 2020Andreas G Frank5,500Open or private sale$89.48$492,140.00
6th October 2020Andreas G Frank5,500Open or private sale$87.50$481,250.00
30th June 2020Mary Kay Ladone2,278Open or private sale$110.00$250,580.00
26th June 2020Mary Kay Ladone3,125Open or private sale$106.00$331,250.00
26th June 2020Mary Kay Ladone3,125Exercise of derivative$53.70$167,812.50
5th June 2020Deborah Rasin3,222Open or private sale$102.81$331,253.82
5th June 2020Deborah Rasin3,222Exercise of derivative$53.70$173,021.40
5th June 2020Deborah Rasin1,800Open or private sale$102.81$185,058.00
Hill Rom Holdings
Hill Rom Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.

Hill-Rom Holdings, Inc. focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following business segments: Patient Support System, Front Line Care, and Surgical Solutions. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Ticker: HRC
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 47518
Employees: 10000
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $332 M (0%)
Inventory, Net: $323 M (0%)
Other Assets, Current: $115 M (7%)
Assets, Current: $1 B (-14%)
Property, Plant and Equipment, Net: $297 M (0%)
Other Assets, Noncurrent: $170 M (86%)
Assets: $5 B (-4%)
Liabilities, Current: $941 M (-25%)
Long-term Debt, Excluding Current Maturities: $2 B (0%)
Other Liabilities, Noncurrent: $127 M (80%)
Liabilities: $3 B (-8%)
Common Stock, Value, Issued: $4 M (0%)
Additional Paid in Capital, Common Stock: $654 M (2%)
Retained Earnings (Accumulated Deficit): $2 B (6%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $212 M (16%)
Treasury Stock, Value: $9 Th (5%)
Stockholders' Equity (Parent): $2 B (5%)
Liabilities and Equity: $5 B (-4%)
Cost of Revenue: $323 M (-65%)
Research and Development: $34 M (-65%)
Operating Income/Loss: $135 M (0%)
Income before taxes: $120 M (0%)
Provision for income taxes: $26 M (-32%)
EPS (basic): $1.41 (0%)
EPS (diluted): $1.4 (0%)